MIR3133

Across TCGA pan-cancer cohorts, MIR3133 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of MIR3133’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR3133 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR3133 is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

STAD, PAAD, and COAD are the cancer types where MIR3133 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3133 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	II,III,IV	+0.362	.013	4	view →
PAAD	Male	All	+1.400	.014	2	view →
COAD	Male	II,III,IV	+0.431	.012	2	view →
LUSC	Female	All	−0.304	.007	2	view →
CHOL	Female	All	+1.196	.010	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

MIR3133–STAD

Open the STAD breakdown →